US Patent Issued to SPRINGWORKS THERAPEUTICS on July 15 for "Dispersible formulations of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereof" (Connecticut Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,597, issued on July 15, was assigned to SPRINGWORKS THERAPEUTICS INC. (Stamford, Conn.).

"Dispersible formulations of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereof" was invented by Kristin Patterson (Stamford, Conn.) and Jiping Liu (Stamford, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to dispersible pharmaceutical compositions comprising N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, and, optionally, a pharmaceutically acceptable carrier."

The patent was filed on Jan. 9, 2023, under Application No. 18/151,707.

*For ...